Public Sector Pension Investment Board Makes New $6.41 Million Investment in The Chemours Company $CC

Key Points

• The Public Sector Pension Investment Board has made a new investment in The Chemours Company, acquiring 473,839 shares valued at approximately $6.41 million, representing 0.32% of the company's total shares.
• Several institutional investors, including Vanguard and Ameriprise Financial, have increased their stakes in Chemours, indicating strong institutional interest in the specialty chemicals company.
• Analysts have mixed opinions on Chemours, with target prices ranging from $14 to $17; the average rating for the stock is currently "Hold" with a target price of $17.38.

Public Sector Pension Investment Board purchased a new position in The Chemours Company (NYSE:CC - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 473,839 shares of the specialty chemicals company's stock, valued at approximately $6,411,000. Public Sector Pension Investment Board owned about 0.32% of Chemours at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of CC. LPL Financial LLC grew its holdings in Chemours by 11.2% in the fourth quarter. LPL Financial LLC now owns 68,797 shares of the specialty chemicals company's stock worth $1,163,000 after purchasing an additional 6,937 shares during the last quarter. Franklin Resources Inc. purchased a new position in Chemours in the fourth quarter worth $283,000. Wells Fargo & Company MN grew its holdings in Chemours by 7.0% in the fourth quarter. Wells Fargo & Company MN now owns 84,369 shares of the specialty chemicals company's stock worth $1,426,000 after purchasing an additional 5,540 shares during the last quarter. Invesco Ltd. grew its holdings in Chemours by 141.5% in the fourth quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company's stock worth $17,238,000 after purchasing an additional 597,638 shares during the last quarter. Finally, Renaissance Technologies LLC grew its holdings in Chemours by 7.3% in the fourth quarter. Renaissance Technologies LLC now owns 288,400 shares of the specialty chemicals company's stock worth $4,874,000 after purchasing an additional 19,500 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on CC. The Goldman Sachs Group cut their price target on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen lowered shares of Chemours from a "hold" rating to a "sell" rating in a report on Wednesday, May 21st. Barclays dropped their price objective on shares of Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 28th. Morgan Stanley dropped their price objective on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a report on Monday, May 12th. Finally, UBS Group dropped their price objective on shares of Chemours from $18.00 to $17.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $17.38.

Insiders Place Their Bets

In other Chemours news, insider Damian Gumpel bought 13,400 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The stock was bought at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the completion of the transaction, the insider directly owned 123,879 shares of the company's stock, valued at approximately $1,142,164.38. This trade represents a 12.13% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Denise Dignam acquired 4,068 shares of the firm's stock in a transaction on Friday, August 8th. The stock was purchased at an average price of $12.06 per share, with a total value of $49,060.08. Following the transaction, the chief executive officer owned 191,546 shares of the company's stock, valued at approximately $2,310,044.76. This trade represents a 2.17% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 25,290 shares of company stock valued at $250,437 over the last 90 days. 0.47% of the stock is currently owned by insiders.

Chemours Stock Performance

NYSE CC traded down $0.2050 on Thursday, reaching $14.1350. 2,535,342 shares of the company's stock traded hands, compared to its average volume of 4,538,503. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of -5.05 and a beta of 1.61. The stock has a 50 day moving average price of $12.81 and a 200-day moving average price of $12.98. The Chemours Company has a fifty-two week low of $9.13 and a fifty-two week high of $22.38. The company has a debt-to-equity ratio of 17.16, a quick ratio of 0.83 and a current ratio of 1.68.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.12. The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.57 billion. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The firm's quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.38 earnings per share. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 15th will be given a dividend of $0.0875 per share. The ex-dividend date is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a yield of 2.5%. Chemours's payout ratio is currently -12.50%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.